Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats

doi:10.3748/wjg.v10.i7.1032

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3747)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

356

HTML

3055

Figures (1-2)

210

Tables (1-4)

126

Sum=3747

Apr 1, 2004 (publication date) through Apr 27, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Apr 1, 2004; 10(7): 1032-1036
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.1032

Table 1 Effect of BPC 157 on indomethacin induced gastric ulcer formation (n = 10)

Administration	Agents	Dosage (ng/kg)	Ulcer (mm²)	Inhibition ratio(%)
im	Saline control		19.22 ± 2.95
	Excipient control		20.90 ± 7.55
	Famotidine	40 000	8.20 ± 4.68	60.8^b
	BPC 157	200	9.71 ± 5.00	53.5^b
	BPC 157	400	7.22 ± 4.01	65.5^b
	BPC 157	800	7.22 ± 4.64	65.5^b
ig	Saline control		20.18 ± 8.50
	Famotidine	40 000	8.28 ± 3.45	58.9^b
	BPC 157	200	13.56 ± 6.79	32.8
	BPC 157	400	9.92 ± 2.62	50.8^b
	BPC 157	800	9.75 ± 5.25	51.7^b

^bP < 0.01 vs excipient control or saline control.

Table 2 Effect of BPC 157 on pylorus ligation induced gastric ulcer formation (n = 10)

Administration	Agents	Dosage (ng/kg)	Ulcer (mm²)	Inhibition ratio(%)
im	Saline control		131.2 ± 58.1
	Excipient control		130.2 ± 68.2
	Famotidine	40 000	55.7 ± 46.7	57.2^b
	BPC 157	200	80.9 ± 22.8	37.8^b
	BPC 157	400	47.6 ± 27.8	63.5^b
	BPC 157	800	44.8 ± 19.4	65.6^b
ig	Saline control		140.1 ± 78.1
	Famotidine	40 000	34.1 ± 33.1	75.7^b
	BPC 157	200	110.5 ± 41.5	21.1
	BPC 157	400	64.1 ± 35.4	54.2^a
	BPC 157	800	58.6 ± 37.6	58.2^b

^aP < 0.05,

^bP < 0.01 vs excipient control (im) or saline control (ig).

Table 3 Effect of BPC 157 on acetate induced gastric ulcer area (n = 10)

Administration	Agents	Dosage (ng/kg)	Ulcer (mm²)	Inhibition ratio(%)
im	Saline control		13.66 ± 4.10
	Excipient control		13.98 ± 4.00
	Famotidine	40 000	9.18 ± 3.04	34.3^a
	BPC 157	200	9.75 ± 3.62	30.2^a
	BPC 157	400	6.81 ± 3.67	51.3^b
	BPC 157	800	5.60 ± 1.91	59.9^b
ig	Saline control		14.96 ± 6.21
	Famotidine	40 000	3.20 ± 1.54	78.6^b
	BPC 157	200	9.78 ± 4.28	34.6^a
	BPC 157	400	8.13 ± 2.84	45.7^b
	BPC 157	800	7.80 ± 2.83	47.8^b

^aP < 0.05,

^bP < 0.01 vs excipient control (im) or saline control (ig).

Table 4 Effects of BPC 157 on rebuilding of glandular epithe-lium and formation of granulation tissue in acetate induced chronic gastric ulcer (n = 10)

Administration	Agent	Dosage (ng/kg)	Diameter of remnant ulcer (μm)	Thickness of granulation tissue (μm)
im	Saline control		3 928 ± 636	718 ± 165
	Excipient control		3 981 ± 594	652 ± 169
	Famotidine	40 000	3 175 ± 577^b	768 ± 268
	BPC 157	200	3 266 ± 671^a	992 ± 295^b
	BPC 157	400	2 658 ± 744^b	1 018 ± 202^b
	BPC 157	800	2 426 ± 511^b	1 012 ± 306^b
ig	Saline control		4 098 ± 795	673 ± 112
	Famotidine	40 000	1 772 ± 458^b	805 ± 100^a
	BPC 157	200	3 260 ± 728^a	797 ± 110^a
	BPC 157	400	2 972 ± 564^b	837 ± 114^b
	BPC 157	800	2 904 ± 577^b	862 ± 171^b

^aP < 0.05,

^bP < 0.01 vs excipient control (im) or saline control (ig).

Citation: Xue XC, Wu YJ, Gao MT, Li WG, Zhao N, Wang ZL, Bao CJ, Yan Z, Zhang YQ. Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats. World J Gastroenterol 2004; 10(7): 1032-1036
URL: https://www.wjgnet.com/1007-9327/full/v10/i7/1032.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i7.1032